• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Analysis of viral diversity for vaccine target discovery

tetano

Editor, Senior Moderator
BMC Med Genomics. 2017 Dec 21;10(Suppl 4):78. doi: 10.1186/s12920-017-0301-2.
[h=1]Analysis of viral diversity for vaccine target discovery.[/h] Khan AM[SUP]1,[/SUP][SUP]2[/SUP], Hu Y[SUP]3[/SUP], Miotto O[SUP]4,[/SUP][SUP]5[/SUP], Thevasagayam NM[SUP]3[/SUP], Sukumaran R[SUP]3[/SUP], Abd Raman HS[SUP]6[/SUP], Brusic V[SUP]7[/SUP], Tan TW[SUP]3[/SUP], Thomas August J[SUP]8[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Viral vaccine target discovery requires understanding the diversity of both the virus and the human immune system. The readily available and rapidly growing pool of viral sequence data in the public domain enable the identification and characterization of immune targets relevant to adaptive immunity. A systematic bioinformatics approach is necessary to facilitate the analysis of such large datasets for selection of potential candidate vaccine targets.
[h=4]RESULTS:[/h] This work describes a computational methodology to achieve this analysis, with data of dengue, West Nile, hepatitis A, HIV-1, and influenza A viruses as examples. Our methodology has been implemented as an analytical pipeline that brings significant advancement to the field of reverse vaccinology, enabling systematic screening of known sequence data in nature for identification of vaccine targets. This includes key steps (i) comprehensive and extensive collection of sequence data of viral proteomes (the virome), (ii) data cleaning, (iii) large-scale sequence alignments, (iv) peptide entropy analysis, (v) intra- and inter-species variation analysis of conserved sequences, including human homology analysis, and (vi) functional and immunological relevance analysis.
[h=4]CONCLUSION:[/h] These steps are combined into the pipeline ensuring that a more refined process, as compared to a simple evolutionary conservation analysis, will facilitate a better selection of vaccine targets and their prioritization for subsequent experimental validation.


[h=4]KEYWORDS:[/h] Bioinformatics; Database; Reverse vaccinology; Target discovery; Tools; Vaccine design; Viral diversity

PMID: 29322922 DOI: 10.1186/s12920-017-0301-2
Free full text
 
Back
Top Bottom